top of page

Biotech General Discussion

Public·97 members

Amp
BPIQ Premium Subscriber

BPIQ Pro

Premium Analyst - Offers a premium marketplace with analysis, portfolios, and more.

Premium Analyst

EPZM - Are you buying at these levels?

$EPZM ($0.52)

Trading below cash

EV~$100M

~3Q cash on hand

#TAZVERIK - approved blood cancer EZH2 methyltrans inhib

See IQ CARD

Q1 '22 $9M

rev '21 $30M

rev '20 $12M


TAZ (#tazemetostat) recently added to NCCN FL guidelines 2nd/3rd line

Death of PI3K inhbs in R/R FL is pos for TAZ

Lots of clinical trial report-outs for Taz in H2 '22

Stock on steady descent since 1) 1/20 #TAZ apprvl & 2) 2/20 biz update (see chart)


Are you buying EPZM at these levels?

Our poll results (after 12 hours):

No: Taz is a bust - 39%

No: Too much competition - 4%

Waiting: for more data - 17%

Yes: Buying at this price - 39%


#EPZM



6 Views
bottom of page